The new radiotracer flurpiridaz is poised to make a major impact on nuclear cardiology. Timothy Bateman, MD, co-director of the cardiovascular radiologic imaging program at Saint Luke's Mid America Heart Institute, shared details on the tracer in a new interview. 

Preventing sudden cardiac arrest involves managing risk factors such as hypertension, hyperlipidemia and diabetes. We spoke to Christina Albert, MD, about this and much more at ESC 2023.

Cardiac CT has been evolving rapidly in recent years. Brian Ghoshhajra, MD, outlined some of the main trends he has seen at the 2023 annual meeting of the Society of Cardiovascular Computed Tomography.

Gregg Stone, MD, discussing the value of IVUS and OCT over angiography to guide PCI procedures and actually improve outcomes based on a 12,000 patient meta analysis presented at ESC 2023.

Agreement aims to use AI to help make cardiology clinical trials more efficient and lead to faster advances in patient care. 

Implementing cardiac CT can make a big impact across the service line without reducing the use of other modalities. Ginger Biesbrock, MedAxiom's executive vice president, explained these findings in a new video interview.

“Given the dramatic difference in death risk for older adults receiving complex PCI, we suggest that such interventions in this exceptionally vulnerable population should be approached with additional caution," researchers wrote. 

A new 57-page report from MedAxiom explored the latest data on compensation, production, staffing and medical imaging offerings among cardiology programs in the United States.